{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T02:37:44Z","timestamp":1711507064915},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11864-017-0451-7","type":"journal-article","created":{"date-parts":[[2017,2,18]],"date-time":"2017-02-18T08:25:01Z","timestamp":1487406301000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Surveillance Scans in Lymphoma: Friend or Foe?"],"prefix":"10.1007","volume":"18","author":[{"given":"Tycel","family":"Phillips","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,18]]},"reference":[{"issue":"6","key":"451_CR1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-12-3837","volume":"102","author":"PA Hamlin","year":"2003","unstructured":"Hamlin PA, Zelenetz AD, Kewalramani T, Qin J, Satagopan JM, Verbel D, et al. Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. Blood. 2003;102(6):1989\u201396.","journal-title":"Blood"},{"issue":"7","key":"451_CR2","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood.V96.7.2399","volume":"96","author":"T Kewalramani","year":"2000","unstructured":"Kewalramani T, Zelenetz AD, Hedrick EE, Donnelly GB, Hunte S, Priovolos AC, et al. High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis. Blood. 2000;96(7):2399\u2013404.","journal-title":"Blood"},{"issue":"1","key":"451_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1536-1632(02)00123-3","volume":"5","author":"E Hemricourt de","year":"2003","unstructured":"de Hemricourt E, De Boeck K, Hilte F, Abib A, Kockx M, Vandevivere J, et al. Sarcoidosis and sarcoid-like reaction following Hodgkin\u2019s disease. Report of two cases. Mol Imaging Biol. 2003;5(1):15\u20139.","journal-title":"Mol Imaging Biol"},{"issue":"31","key":"451_CR4","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1200\/JCO.2005.08.107","volume":"23","author":"D Hollister Jr","year":"2005","unstructured":"Hollister Jr D, Lee MS, Eisen RN, Fey C, Portlock CS. Variable problems in lymphomas: case 2. Sarcoidosis mimicking progressive lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(31):8113\u20136.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology."},{"issue":"11","key":"451_CR5","first-page":"1789","volume":"44","author":"HW Yeung","year":"2003","unstructured":"Yeung HW, Grewal RK, Gonen M, Schoder H, Larson SM. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med. 2003;44(11):1789\u201396.","journal-title":"J Nucl Med"},{"issue":"6","key":"451_CR6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/10428194.2011.639882","volume":"53","author":"GA Abel","year":"2012","unstructured":"Abel GA, Vanderplas A, Rodriguez MA, Crosby AL, Czuczman MS, Niland JC, et al. High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database. Leukemia & lymphoma. 2012;53(6):1113\u20136.","journal-title":"Leukemia & lymphoma."},{"issue":"6","key":"451_CR7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/annonc\/mdl049","volume":"17","author":"M Liedtke","year":"2006","unstructured":"Liedtke M, Hamlin PA, Moskowitz CH, Zelenetz AD. Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population. Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO. 2006;17(6):909\u201313.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO."},{"issue":"6","key":"451_CR8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ajh.23688","volume":"89","author":"TC El-Galaly","year":"2014","unstructured":"El-Galaly TC, Mylam KJ, Bogsted M, Brown P, Rossing M, Gang AO, et al. Role of routine imaging in detecting recurrent lymphoma: a review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma. Am J Hematol. 2014;89(6):575\u201380.","journal-title":"Am J Hematol"},{"issue":"1","key":"451_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/annonc\/mdg011","volume":"14","author":"G Jerusalem","year":"2003","unstructured":"Jerusalem G, Beguin Y, Fassotte MF, Belhocine T, Hustinx R, Rigo P, et al. Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin\u2019s disease. Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO. 2003;14(1):123\u201330.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO."},{"issue":"11","key":"451_CR10","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1200\/JCO.2008.16.1513","volume":"27","author":"PL Zinzani","year":"2009","unstructured":"Zinzani PL, Stefoni V, Tani M, Fanti S, Musuraca G, Castellucci P, et al. Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(11):1781\u20137.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology."},{"issue":"4","key":"451_CR11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/10428194.2010.547642","volume":"52","author":"T El-Galaly","year":"2011","unstructured":"El-Galaly T, Prakash V, Christiansen I, Madsen J, Johansen P, Boegsted M, et al. Efficacy of routine surveillance with positron emission tomography\/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center. Leukemia & lymphoma. 2011;52(4):597\u2013603.","journal-title":"Leukemia & lymphoma."},{"issue":"8","key":"451_CR12","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/annonc\/mdq015","volume":"21","author":"U Petrausch","year":"2010","unstructured":"Petrausch U, Samaras P, Haile SR, Veit-Haibach P, Soyka JD, Knuth A, et al. Risk-adapted FDG-PET\/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy. Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO. 2010;21(8):1694\u20138.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO."},{"issue":"5","key":"451_CR13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/annonc\/mdp519","volume":"21","author":"U Petrausch","year":"2010","unstructured":"Petrausch U, Samaras P, Veit-Haibach P, Tschopp A, Soyka JD, Knuth A, et al. Hodgkin\u2019s lymphoma in remission after first-line therapy: which patients need FDG-PET\/CT for follow-up? Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO. 2010;21(5):1053\u20137.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO."},{"issue":"16","key":"451_CR14","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1002\/cncr.25240","volume":"116","author":"AI Lee","year":"2010","unstructured":"Lee AI, Zuckerman DS, Van den Abbeele AD, Aquino SL, Crowley D, Toomey C, et al. Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis. Cancer. 2010;116(16):3835\u201342.","journal-title":"Cancer"},{"issue":"12","key":"451_CR15","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00277-009-0752-4","volume":"88","author":"R Crocchiolo","year":"2009","unstructured":"Crocchiolo R, Fallanca F, Giovacchini G, Ferreri AJ, Assanelli A, Verona C, et al. Role of 18FDG-PET\/CT in detecting relapse during follow-up of patients with Hodgkin\u2019s lymphoma. Ann Hematol. 2009;88(12):1229\u201336.","journal-title":"Ann Hematol"},{"issue":"7077","key":"451_CR16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bmj.314.7077.343a","volume":"314","author":"JA Radford","year":"1997","unstructured":"Radford JA, Eardley A, Woodman C, Crowther D. Follow up policy after treatment for Hodgkin\u2019s disease: too many clinic visits and routine tests? A review of hospital records. BMJ. 1997;314(7077):343\u20136.","journal-title":"BMJ"},{"issue":"10","key":"451_CR17","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/blood-2007-06-097238","volume":"110","author":"P Seam","year":"2007","unstructured":"Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood. 2007;110(10):3507\u201316.","journal-title":"Blood"},{"issue":"7","key":"451_CR18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1200\/JCO.1991.9.7.1196","volume":"9","author":"JC Weeks","year":"1991","unstructured":"Weeks JC, Yeap BY, Canellos GP, Shipp MA. Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991;9(7):1196\u2013203.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology."},{"issue":"5","key":"451_CR19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajh.23423","volume":"88","author":"I Avivi","year":"2013","unstructured":"Avivi I, Zilberlicht A, Dann EJ, Leiba R, Faibish T, Rowe JM, et al. Strikingly high false positivity of surveillance FDG-PET\/CT scanning among patients with diffuse large cell lymphoma in the rituximab era. Am J Hematol. 2013;88(5):400\u20135.","journal-title":"Am J Hematol"},{"issue":"2","key":"451_CR20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/bjc.2013.338","volume":"109","author":"CY Cheah","year":"2013","unstructured":"Cheah CY, Hofman MS, Dickinson M, Wirth A, Westerman D, Harrison SJ, et al. Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy. Br J Cancer. 2013;109(2):312\u20137.","journal-title":"Br J Cancer"},{"issue":"6","key":"451_CR21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3324\/haematol.2011.056010","volume":"97","author":"TC El-Galaly","year":"2012","unstructured":"El-Galaly TC, Mylam KJ, Brown P, Specht L, Christiansen I, Munksgaard L, et al. Positron emission tomography\/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs. Haematologica. 2012;97(6):931\u20136.","journal-title":"Haematologica"},{"issue":"1","key":"451_CR22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/1042819021000040323","volume":"44","author":"AE Guppy","year":"2003","unstructured":"Guppy AE, Tebbutt NC, Norman A, Cunningham D. The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin\u2019s lymphoma. Leukemia & lymphoma. 2003;44(1):123\u20135.","journal-title":"Leukemia & lymphoma."},{"issue":"2","key":"451_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00277-010-1044-8","volume":"90","author":"N Goldschmidt","year":"2011","unstructured":"Goldschmidt N, Or O, Klein M, Savitsky B, Paltiel O. The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. Ann Hematol. 2011;90(2):165\u201371.","journal-title":"Ann Hematol"},{"issue":"11","key":"451_CR24","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00277-012-1508-0","volume":"91","author":"TL Lin","year":"2012","unstructured":"Lin TL, Kuo MC, Shih LY, Dunn P, Wang PN, Wu JH, et al. Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas. Ann Hematol. 2012;91(11):1741\u20135.","journal-title":"Ann Hematol"},{"issue":"1","key":"451_CR25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clml.2013.08.009","volume":"14","author":"Q Truong","year":"2014","unstructured":"Truong Q, Shah N, Knestrick M, Curley B, Hu Y, Craig M, et al. Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission. Clin Lymphoma Myeloma Leuk. 2014;14(1):50\u20135.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"34","key":"451_CR26","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1200\/JCO.2015.62.0229","volume":"33","author":"TC El-Galaly","year":"2015","unstructured":"\u2022\u2022 El-Galaly TC, Jakobsen LH, Hutchings M, de Nully BP, Nilsson-Ehle H, Szekely E, et al. Routine imaging for diffuse large B-cell lymphoma in first complete remission does not improve post-treatment survival: a Danish-Swedish population-based study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015;33(34):3993\u20138. A large retrospective study that evaluated two large patient populations that had different standard surveillance practices","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"31","key":"451_CR27","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1200\/JCO.2014.55.7561","volume":"32","author":"CA Thompson","year":"2014","unstructured":"\u2022\u2022 Thompson CA, Ghesquieres H, Maurer MJ, Cerhan JR, Biron P, Ansell SM, et al. Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32(31):3506\u201312. A large retrospective study to demonstrate the lack of survival benefit with routine CT imaging","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"451_CR28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1148\/radiology.210.2.r99fe63483","volume":"210","author":"YK Oh","year":"1999","unstructured":"Oh YK, Ha CS, Samuels BI, Cabanillas F, Hess MA, Cox JD. Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies. Radiology. 1999;210(2):483\u20136.","journal-title":"Radiology"},{"issue":"7","key":"451_CR29","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3324\/haematol.2009.020115","volume":"95","author":"M Gerlinger","year":"2010","unstructured":"Gerlinger M, Rohatiner AZ, Matthews J, Davies A, Lister TA, Montoto S. Surveillance investigations after high-dose therapy with stem cell rescue for recurrent follicular lymphoma have no impact on management. Haematologica. 2010;95(7):1130\u20135.","journal-title":"Haematologica"},{"issue":"10","key":"451_CR30","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3109\/10428194.2013.767902","volume":"54","author":"V Patel","year":"2013","unstructured":"Patel V, Buckstein M, Perini R, Hill-Kayser C, Svoboda J, Plastaras JP. Computed tomography and positron emission tomography\/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective. Leukemia & lymphoma. 2013;54(10):2168\u201376.","journal-title":"Leukemia & lymphoma"},{"issue":"3","key":"451_CR31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/sj.bjc.6601052","volume":"89","author":"ET Dryver","year":"2003","unstructured":"Dryver ET, Jernstrom H, Tompkins K, Buckstein R, Imrie KR. Follow-up of patients with Hodgkin\u2019s disease following curative treatment: the routine CT scan is of little value. Br J Cancer. 2003;89(3):482\u20136.","journal-title":"Br J Cancer"},{"issue":"16","key":"451_CR32","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.2010.460","volume":"303","author":"MA Dinan","year":"2010","unstructured":"Dinan MA, Curtis LH, Hammill BG, Patz Jr EF, Abernethy AP, Shea AM, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA. 2010;303(16):1625\u201331.","journal-title":"JAMA"},{"issue":"25","key":"451_CR33","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1200\/JCO.2006.07.0409","volume":"24","author":"BA Guadagnolo","year":"2006","unstructured":"Guadagnolo BA, Punglia RS, Kuntz KM, Mauch PM, Ng AK. Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin\u2019s disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(25):4116\u201322.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"11","key":"451_CR34","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/annonc\/mdq215","volume":"21","author":"CA Thompson","year":"2010","unstructured":"Thompson CA, Charlson ME, Schenkein E, Wells MT, Furman RR, Elstrom R, et al. Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO. 2010;21(11):2262\u20136.","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO"},{"issue":"5","key":"451_CR35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.HP.0000326333.42287.a2","volume":"95","author":"FA Mettler Jr","year":"2008","unstructured":"Mettler Jr FA, Thomadsen BR, Bhargavan M, Gilley DB, Gray JE, Lipoti JA, et al. Medical radiation exposure in the U.S. in 2006: preliminary results. Health Phys. 2008;95(5):502\u20137.","journal-title":"Health Phys"},{"issue":"1","key":"451_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.HP.0000356672.44380.b7","volume":"97","author":"DA Schauer","year":"2009","unstructured":"Schauer DA, Linton OW. NCRP report no. 160, ionizing radiation exposure of the population of the United States, medical exposure\u2014are we doing less with more, and is there a role for health physicists? Health Phys. 2009;97(1):1\u20135.","journal-title":"Health Phys"},{"issue":"22","key":"451_CR37","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMra072149","volume":"357","author":"DJ Brenner","year":"2007","unstructured":"Brenner DJ, Hall EJ. Computed tomography\u2014an increasing source of radiation exposure. N Engl J Med. 2007;357(22):2277\u201384.","journal-title":"N Engl J Med"},{"issue":"1","key":"451_CR38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1148\/radiol.2511081300","volume":"251","author":"B Huang","year":"2009","unstructured":"Huang B, Law MW, Khong PL. Whole-body PET\/CT scanning: estimation of radiation dose and cancer risk. Radiology. 2009;251(1):166\u201374.","journal-title":"Radiology"},{"issue":"6","key":"451_CR39","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejrad.2014.02.015","volume":"83","author":"R Guttikonda","year":"2014","unstructured":"Guttikonda R, Herts BR, Dong F, Baker ME, Fenner KB, Pohlman B. Estimated radiation exposure and cancer risk from CT and PET\/CT scans in patients with lymphoma. Eur J Radiol. 2014;83(6):1011\u20135.","journal-title":"Eur J Radiol"},{"issue":"9","key":"451_CR40","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s00330-012-2447-9","volume":"22","author":"RA Nievelstein","year":"2012","unstructured":"Nievelstein RA, Quarles van Ufford HM, Kwee TC, Bierings MB, Ludwig I, Beek FJ, et al. Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma. Eur Radiol. 2012;22(9):1946\u201354.","journal-title":"Eur Radiol"},{"issue":"1","key":"451_CR41","doi-asserted-by":"crossref","first-page":"W81","DOI":"10.2214\/AJR.12.9226","volume":"201","author":"JM Albert","year":"2013","unstructured":"Albert JM. Radiation risk from CT: implications for cancer screening. AJR Am J Roentgenol. 2013;201(1):W81\u20137.","journal-title":"AJR Am J Roentgenol"},{"issue":"9406","key":"451_CR42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(04)15433-0","volume":"363","author":"A Berrington de Gonzalez","year":"2004","unstructured":"Berrington de Gonzalez A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet. 2004;363(9406):345\u201351.","journal-title":"Lancet"},{"issue":"22","key":"451_CR43","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1001\/archinternmed.2009.440","volume":"169","author":"A Berrington de Gonzalez","year":"2009","unstructured":"Berrington de Gonzalez A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009;169(22):2071\u20137.","journal-title":"Arch Intern Med"},{"issue":"8","key":"451_CR44","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/thoraxjnl-2014-205499","volume":"69","author":"AS Brody","year":"2014","unstructured":"Brody AS, Guillerman RP. Don\u2019t let radiation scare trump patient care: 10 ways you can harm your patients by fear of radiation-induced cancer from diagnostic imaging. Thorax. 2014;69(8):782\u20134.","journal-title":"Thorax"},{"issue":"1","key":"451_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HP.0b013e3182690c8e","volume":"104","author":"R Calandrino","year":"2013","unstructured":"Calandrino R, Ardu V, Corletto D, del Vecchio A, Origgi D, Signorotto P, et al. Evaluation of second cancer induction risk by CT follow-up in oncological long-surviving patients. Health Phys. 2013;104(1):1\u20138.","journal-title":"Health Phys"},{"issue":"2","key":"451_CR46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1148\/radiol.12112678","volume":"264","author":"WR Hendee","year":"2012","unstructured":"Hendee WR, O'Connor MK. Radiation risks of medical imaging: separating fact from fantasy. Radiology. 2012;264(2):312\u201321.","journal-title":"Radiology"},{"issue":"12","key":"451_CR47","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jacr.2009.09.014","volume":"6","author":"M Mahesh","year":"2009","unstructured":"Mahesh M. NCRP report number 160: its significance to medical imaging. J Am Coll Radiol. 2009;6(12):890\u20132.","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"451_CR48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1148\/radiol.2511081296","volume":"251","author":"A Sodickson","year":"2009","unstructured":"Sodickson A, Baeyens PF, Andriole KP, Prevedello LM, Nawfel RD, Hanson R, et al. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology. 2009;251(1):175\u201384.","journal-title":"Radiology"},{"issue":"3","key":"451_CR49","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ijc.29433","volume":"137","author":"SH Chien","year":"2015","unstructured":"\u2022 Chien SH, Liu CJ, Hu YW, Hong YC, Teng CJ, Yeh CM, et al. Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: a nationwide population-based study. Int J Cancer. 2015;137(3):658\u201365. The most recent study to determine the radiation risk with the use of routine imaging","journal-title":"Int J Cancer"},{"key":"451_CR50","doi-asserted-by":"crossref","unstructured":"Lynch RC, Zelenetz AD, Armitage JO, Carson KR. Surveillance imaging for lymphoma: pros and cons. Am Soc Clin Oncol Educ Book. 2014:e388\u201395.","DOI":"10.14694\/EdBook_AM.2014.34.e388"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-017-0451-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-017-0451-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-017-0451-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T17:43:36Z","timestamp":1601660616000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-017-0451-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1007\/s11864-017-0451-7","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]},"article-number":"10"}}